3 months Free Trail

Get world class research developed by an in house team of professionals backed with strong institutional support. With reports that span across time horizons, styles and easily actionable strategies, you are never too far from executing a winning trade.

Key features and benefits of Registeration :
  • My Portfolio : Access 360° View not only of your Portfolio with Emkay, but all your Investment Portfolios
  • Emkay Research : Get Emkay's exclusive Research Reports & Trading Ideas.
  • My Watch list : Track your favorite stocks, Derivatives, Currencies, Commodities, Mutual funds on the go
  • Markets : Grab Stock Market Information at your fingertips
  • News & Announcements : Stay Updated 24x7 with news that matters.
  • Alerts : Get Alerts on Emkay Research, Trading Ideas, news on your portfolio holdings & watchlist

Generate password

Change password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Patients save Rs. 11,462 crores under Government initiative

Share Source By

Dion Global

19 Dec 2018

Minister of State for Road Transport and Highways, Shipping and Chemicals and Fertilizers, Mansukh L. Mandaviya, while giving a written reply to a question on Government’s initiative of ensuring affordable, quality medicines for all, in Lok Sabha today, stated that ceiling prices of 856 medicines have been fixed by the National Pharmaceutical Pricing Authority (NPPA), resulting in a saving of Rs. 11,462 crore for patients (as on 30th November 2018).

Mandaviya also said that after fixing the ceiling price of coronary stents, NPPA has been closely watching their availability in the country and no shortage has been reported so far in this regard. At present, prices have been fixed by NPPA for 856 formulations, including 4 medical devices, which are covered under Schedule–I of the DPCO, 2013.

As per Paragraph 20 of the DPCO 2013, NPPA monitors the Maximum Retail Prices (MRPs) of all drugs, including the non-scheduled formulations and ensures that no manufacturer increases the maximum retail price of a drug more than ten percent of maximum retail price in preceding twelve months. NPPA is effectively monitoring the prices of medicines including the non-scheduled formulations and takes action against companies found overcharging.

The Department of Pharmaceuticals has also launched a Scheme ‘Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)’ in order to make quality generic medicines at affordable prices to all through specific outlets. As on date, 4571 PMBJP outlets are functional across the country, Mandaviya stated.